论文信息 - Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients - 字舞流文

Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients

H. Rammensee | S. Stevanović | A. Stenzl | J. Hennenlotter | S. Pascolo | R. Klein | S. Attig | C. Gouttefangeas | D. Wernet | S. Feyerabend | H. Griesemann | M. Widenmeyer | D. V. Kuprash | A. Y. Sazykin